PubMed:18199556 / 1610-1860 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/18199556","sourcedb":"PubMed","sourceid":"18199556","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/18199556","text":"These data suggest that Hsp90 inhibition in combination with chemotherapy may represent an effective treatment strategy for patients whose tumors express EGFR kinase domain mutations, including those with de novo and acquired resistance to EGFR TKIs.","tracks":[{"project":"sentences","denotations":[{"id":"TextSentencer_T11","span":{"begin":0,"end":250},"obj":"Sentence"},{"id":"T11","span":{"begin":0,"end":250},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T11","pred":"source","obj":"sentences"},{"subj":"T11","pred":"source","obj":"sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#ecdb93","default":true}]}]}}